Home › Calculator › TOVX Dividend Calculator 2026
TOVX Dividend DRIP Calculator 2026
905.80% YieldHealthcareTheriva Biologics, Inc. · AMEX
Price: $0.22 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TOVX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your TOVX snowball 📈
$10,000 in TOVX → $105950691.90M in 10 years · $7,951,390,782,690.04/month
About Theriva Biologics, Inc. (TOVX) — Dividend Analysis 2026
Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome damage, Clostridioides difficile infection (CDI), the overgrowth of harmful organisms, the rise of antimicrobial resistance (AMR), and acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants. Another key investigational therapy is SYN-020, an orally administered recombinant formulation of intestinal alkaline phosphatase, designed to address both localized gastrointestinal and systemic diseases. Additionally, Theriva Biologics is advancing VCN-01 for the treatment of various cancers, specifically pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. Its broader clinical-stage portfolio includes SYN-006, intended to prevent aGVHD and infections caused by carbapenem-resistant enterococci; SYN-007, aimed at preventing antibiotic-associated diarrhea linked to oral beta-lactam antibiotics; SYN-005, for both the prevention and treatment of pertussis; and VCN-11, another cancer-focused therapy. The company collaborates with institutions such as Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center. Furthermore, a clinical trial agreement with Washington University School of Medicine in St. Louis is in place to conduct a Phase 1b/2a clinical trial for SYN-004. Formerly known as Synthetic Biologics, Inc., the company rebranded as Theriva Biologics Inc. in October 2022 and is headquartered in Rockville, Maryland.
Compare TOVX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TOVX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TOVX position with:
🌍 TOVX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TOVX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 905.80% | 903.00% | $90,580 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 769.93% | 767.13% | $76,993 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 724.64% | 721.84% | $72,464 / yr |
| 🇬🇧 UK ISA | 0% | 905.80% | 903.00% | $90,580 / yr |
| 🇬🇧 UK Taxable | 8.75% | 826.54% | 823.74% | $82,654 / yr |
| 🇨🇦 TFSA | 0% | 905.80% | 903.00% | $90,580 / yr |
| 🇨🇦 CA Taxable | 25% | 679.35% | 676.55% | $67,935 / yr |
| 🇦🇺 Super (pension) | 15% | 769.93% | 767.13% | $76,993 / yr |
| 🇦🇺 AU Taxable | 30% | 634.06% | 631.26% | $63,406 / yr |
| 🇩🇪 DE Taxable | 26.375% | 666.90% | 664.10% | $66,690 / yr |
| 🇫🇷 FR Taxable | 30% | 634.06% | 631.26% | $63,406 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TOVX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TOVX Dividend Payment Schedule
TOVX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 TOVX vs Healthcare Benchmarks
How TOVX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TOVX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TOVX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-01-05 | 475,000 | $0.24 | $114.5K | ||
| A-Award | 2026-01-05 | 75,000 | $0.24 | $18.1K | ||
| A-Award | 2026-01-05 | 75,000 | $0.24 | $18.1K | ||
| A-Award | 2026-01-05 | 75,000 | $0.24 | $18.1K | ||
| A-Award | 2025-04-29 | 25,000 | $1.41 | $35.4K | ||
| A-Award | 2025-04-29 | 190,000 | $1.41 | $268.7K | ||
| A-Award | 2025-04-29 | 25,000 | $1.41 | $35.4K | ||
| A-Award | 2025-04-29 | 25,000 | $1.41 | $35.4K | ||
| A-Award | 2023-12-14 | 700,000 | $0.59 | $411.3K | ||
| A-Award | 2023-12-14 | 110,000 | $0.59 | $64.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TOVX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Theriva Biologics, Inc. (TOVX) is currently trading at $0.22, 100% below its 52-week high. The current dividend yield is 905.80% based on an annual payout of $2.00 per share.
TOVX (Theriva Biologics, Inc.) — 905.80% Dividend Yield Analysis
Theriva Biologics, Inc. (TOVX) is a healthcare stock currently trading at $0.22 with a dividend yield of 905.80%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (905.80%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.